# Top 50 Oncology Startups Worldwide by Funding (2026)

> The 50 best-funded oncology startups worldwide, ranked by total funding raised: $12B combined. With founding year, headquarters and each company's rounds.

Source: https://millionrounds.com/top-lists/oncology-startups (Millionrounds; every figure on the page links to its filing or article)

- 1 [**Blueprint Medicines** Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.](https://millionrounds.com/company/blueprint-medicines) Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. *Founded* 2011 Cambridge, United States **$1.4B** last round Jun 2022
- 2 [**Erasca** Erasca is a developer of oncology drugs intended to provide precision oncology options.](https://millionrounds.com/company/erasca) Erasca is a developer of oncology drugs intended to provide precision oncology options. *Founded* 2018 San Diego, United States **$739M** last round Jul 2026
- 3 [**Nuvation Bio** Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.](https://millionrounds.com/company/nuvation-bio) Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology. *Founded* 2018 New York, United States **$675M** last round Jun 2026
- 4 [**IDEAYA Biosciences** IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.](https://millionrounds.com/company/ideaya-biosciences) IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers. *Founded* 2015 South San Francisco, United States **$608M** last round Jun 2026
- 5 [**Tyra Biosciences** Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.](https://millionrounds.com/company/tyra-biosciences) Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs. *Founded* 2018 Carlsbad, United States **$600M** last round Sept 2026
- 6 [**Legend Biotech** Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.](https://millionrounds.com/company/legend-biotech) Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology. *Founded* 2015 Piscataway, United States **$576M** last round Jun 2026
- 7 [**Enliven Therapeutics** Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.](https://millionrounds.com/company/enliven-therapeutics) Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. *Founded* 2019 Boulder, United States **$460M** last round Jun 2026
- 8 [**21st Century Oncology** 21st Century Oncology is a medical care center that offers cancer care services.](https://millionrounds.com/company/21st-century-oncology) 21st Century Oncology is a medical care center that offers cancer care services. *Founded* 1983 Fort Myers, United States **$325M** last round Sept 2014
- 9 [**Coherus Biosciences** Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.](https://millionrounds.com/company/coherus-biosciences) Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases. *Founded* 2010 Redwood City, United States **$299M** last round Feb 2026
- 10 [**Repare Therapeutics** Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.](https://millionrounds.com/company/repare-therapeutics) Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. *Founded* 2016 Saint Laurent, Canada **$252M** last round Oct 2021
- 11 [**Odyssey Therapeutics** Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.](https://millionrounds.com/company/odyssey-therapeutics) Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases. *Founded* 2021 Boston, United States **$238M** last round May 2026
- 12 [**CG Oncology** CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.](https://millionrounds.com/company/cg-oncology) CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer. *Founded* 2010 Irvine, United States **$238M** last round Dec 2024
- 13 [**InventisBio** InventisBio is a clinical-stage biopharmaceutical company based in Shanghai, China, with operations in New Jersey, USA.](https://millionrounds.com/company/inventisbio) InventisBio is a clinical-stage biopharmaceutical company based in Shanghai, China, with operations in New Jersey, USA. *Founded* 2013 Shanghai, China **$236M** last round Sept 2020
- 14 [**Solstice Oncology** Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.](https://millionrounds.com/company/solstice-oncology) Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches. *Founded* - Boston, United States **$225M** last round Sept 2026
- 15 [**Thyme Care** Thyme Care is an oncology care management company based in Nashville, Tennessee, founded in 2020 by Robin Shah and Bobby Green.](https://millionrounds.com/company/thyme-care) Thyme Care is an oncology care management company based in Nashville, Tennessee, founded in 2020 by Robin Shah and Bobby Green. *Founded* 2020 Nashville, United States **$222M** last round Sept 2026
- 16 [**Kura Oncology** Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.](https://millionrounds.com/company/kura-oncology) Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers. *Founded* 2014 La Jolla, United States **$210M** last round Jan 2024
- 17 [**BostonGene** BostonGene is a biotechnology company based in Waltham, Massachusetts, founded in 2015.](https://millionrounds.com/company/bostongene) BostonGene is a biotechnology company based in Waltham, Massachusetts, founded in 2015. *Founded* 2015 Waltham, United States **$200M** last round Apr 2022
- 18 [**X4 Pharmaceuticals** X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.](https://millionrounds.com/company/x4-pharmaceuticals) X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment. *Founded* 2012 Cambridge, United States **$193M** last round Oct 2025
- 19 [**Nouscom** Nouscom is a clinical-stage immuno-oncology company founded in 2015 and based in Basel, Switzerland, with operational facilities in Rome, Italy.](https://millionrounds.com/company/nouscom) Nouscom is a clinical-stage immuno-oncology company founded in 2015 and based in Basel, Switzerland, with operational facilities in Rome, Italy. *Founded* 2015 Basel, Switzerland **$191M** last round Oct 2026
- 20 [**Harbour BioMed** Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.](https://millionrounds.com/company/harbour-biomed) Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology. *Founded* - China **$190M** last round Mar 2025
- 21 [**Cartesian Therapeutics** Pioneering Potent, Safer Cell Therapy in and Beyond Oncology](https://millionrounds.com/company/cartesian-therapeutics) Pioneering Potent, Safer Cell Therapy in and Beyond Oncology *Founded* 2016 Gaithersburg, United States **$180M** last round May 2026
- 22 [**Antares Therapeutics** Antares Therapeutics, Inc.](https://millionrounds.com/company/antares-therapeutics) Antares Therapeutics, Inc. *Founded* - Boston, United States **$177M** last round May 2025
- 23 [**Aktis Oncology** Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.](https://millionrounds.com/company/aktis-oncology) Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals. *Founded* 2021 Boston, United States **$175M** last round Sept 2024
- 24 [**Mariana Oncology** Mariana Oncology is a biotechnology research industry.](https://millionrounds.com/company/mariana-oncology) Mariana Oncology is a biotechnology research industry. *Founded* 2021 Watertown, United States **$175M** last round Sept 2023
- 25 [**Alpha-9 Oncology** Alpha-9 Oncology is a clinical-stage radiopharmaceutical company focused on developing targeted treatments for cancer.](https://millionrounds.com/company/alpha-9-oncology) Alpha-9 Oncology is a clinical-stage radiopharmaceutical company focused on developing targeted treatments for cancer. *Founded* 2019 Boston, Canada **$175M** last round Oct 2024
- 26 [**Alphamab Oncology**](https://millionrounds.com/company/alphamab-oncology) *Founded* - China **$160M** last round May 2019
- 27 [**Cerulean Pharma** Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.](https://millionrounds.com/company/cerulean-pharma) Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases. *Founded* 2006 San Diego, United States **$152M** last round Apr 2015
- 28 [**Scorpion Therapeutics** Scorpion Therapeutics is a clinical-stage biotechnology company specializing in precision oncology.](https://millionrounds.com/company/scorpion-therapeutics) Scorpion Therapeutics is a clinical-stage biotechnology company specializing in precision oncology. *Founded* 2020 Boston, United States **$150M** last round Jul 2024
- 29 [**MOMA Therapeutics** MOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020.](https://millionrounds.com/company/moma-therapeutics) MOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020. *Founded* 2020 Cambridge, United States **$150M** last round May 2022
- 30 [**Clasp Therapeutics** Clasp Therapeutics is a clinical-stage biotechnology company founded in 2020, focused on precision immuno-oncology.](https://millionrounds.com/company/clasp-therapeutics) Clasp Therapeutics is a clinical-stage biotechnology company founded in 2020, focused on precision immuno-oncology. *Founded* 2020 Baltimore, United States **$150M** last round Mar 2024
- 31 [**Cullinan Oncology**](https://millionrounds.com/company/cullinan-oncology) *Founded* - United States **$150M** last round Oct 2017
- 32 [**ConcertAI** ConcertAI is an AI-powered SaaS data company in healthcare that develops medical research tool in oncology.](https://millionrounds.com/company/concertai) ConcertAI is an AI-powered SaaS data company in healthcare that develops medical research tool in oncology. *Founded* 2018 Cambridge, United States **$150M** last round Mar 2022
- 33 [**Monopar** Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.](https://millionrounds.com/company/monopar) Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds. *Founded* 2014 Wilmette, United States **$147M** last round Sept 2025
- 34 [**Kolltan Pharmaceuticals** Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.](https://millionrounds.com/company/kolltan-pharmaceuticals) Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics. *Founded* 2007 New Haven, United States **$146M** last round Mar 2014
- 35 [**Boundless Bio** Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.](https://millionrounds.com/company/boundless-bio) Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers. *Founded* 2018 La Jolla, United States **$146M** last round May 2023
- 36 [**Abdera Therapeutics** Abdera Therapeutics is a precision oncology company based in South San Francisco, California, with an additional office in Vancouver, Canada.](https://millionrounds.com/company/abdera-therapeutics) Abdera Therapeutics is a precision oncology company based in South San Francisco, California, with an additional office in Vancouver, Canada. *Founded* 2020 South San Francisco, Canada **$142M** last round Apr 2023
- 37 [**Avistone Pharmaceuticals** Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.](https://millionrounds.com/company/avistone-pharmaceuticals) Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics. *Founded* 2011 China **$141M** last round Dec 2023
- 38 [**Caribou Biosciences** Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.](https://millionrounds.com/company/caribou-biosciences) Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology. *Founded* 2011 Berkeley, United States **$139M** last round Jul 2023
- 39 [**Ellipses Pharma** Ellipses Pharma is a London-based oncology-focused drug development company that aims to accelerate the discovery and clinical advancement of innovative cancer medicines.](https://millionrounds.com/company/ellipses-pharma) Ellipses Pharma is a London-based oncology-focused drug development company that aims to accelerate the discovery and clinical advancement of innovative cancer medicines. *Founded* 2015 London, United Kingdom **$136M** last round Dec 2025
- 40 [**Innate Pharma** Innate Pharma S.A.](https://millionrounds.com/company/innate-pharma) Innate Pharma S.A. *Founded* 1999 Marseille, France **$134M** last round Jun 2014
- 41 [**Acrivon Therapeutics** Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.](https://millionrounds.com/company/acrivon-therapeutics) Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success. *Founded* 2018 Cambridge, United States **$130M** last round Apr 2024
- 42 [**Galvanize** Galvanize Therapeutics is a commercial-stage medical technology company based in San Carlos, California.](https://millionrounds.com/company/galvanize) Galvanize Therapeutics is a commercial-stage medical technology company based in San Carlos, California. *Founded* 2015 Redwood City, United States **$125M** last round Jan 2019
- 43 [**2seventy bio** 2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.](https://millionrounds.com/company/2seventy-bio) 2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies. *Founded* 2021 Cambridge, United States **$125M** last round Feb 2023
- 44 [**Flare Therapeutics** Flare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.](https://millionrounds.com/company/flare-therapeutics) Flare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021. *Founded* 2021 Cambridge, United States **$123M** last round Mar 2023
- 45 [**Nexo Therapeutics** Nexo Therapeutics is a biotechnology company dedicated to discovering and developing small-molecule therapies, particularly in oncology and for challenging dise](https://millionrounds.com/company/nexo-therapeutics) Nexo Therapeutics is a biotechnology company dedicated to discovering and developing small-molecule therapies, particularly in oncology and for challenging dise *Founded* 2022 Watertown, United States **$120M** last round Mar 2026
- 46 [**Virogin Biotech** Virogin Biotech is a clinical-stage immuno-oncology company based in Richmond/Vancouver, British Columbia, Canada.](https://millionrounds.com/company/virogin-biotech) Virogin Biotech is a clinical-stage immuno-oncology company based in Richmond/Vancouver, British Columbia, Canada. *Founded* 2015 Richmond, Canada **$120M** last round Sept 2021
- 47 [**Microbiotica** Microbiotica is a clinical-stage biopharmaceutical company based in Cambridge, UK, founded in 2016.](https://millionrounds.com/company/microbiotica) Microbiotica is a clinical-stage biopharmaceutical company based in Cambridge, UK, founded in 2016. *Founded* 2016 Saffron Walden, United Kingdom **$117M** last round Sept 2026
- 48 [**Vor Biopharma** Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.](https://millionrounds.com/company/vor-biopharma) Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. *Founded* 2016 Cambridge, United States **$117M** last round Mar 2026
- 49 [**Apollomics** Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.](https://millionrounds.com/company/apollomics) Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system. *Founded* - Foster City, United States **$116M** last round Aug 2026
- 50 [**MISSION Therapeutics** Mission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and development, particularly in oncology a](https://millionrounds.com/company/mission-therapeutics) Mission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and development, particularly in oncology a *Founded* 2011 Cambridge, United Kingdom **$113M** last round Oct 2025

**Total funding** how the list is ranked

**15 November 2026** updated nightly

**Rounds we track** source: Millionrounds

Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.

## Who backed them?

Open any company for its rounds and investors, or search the investors who back oncology startups worldwide in the app, with filters, lists and exports.

[Find their investors](https://millionrounds.com/login?join=1&next=/app/investors)[All top lists](https://millionrounds.com/top-lists)

## More oncology lists

[See all](https://millionrounds.com/top-lists?t=Oncology)

[*N* *EP* *IP* **Oncology startups in Europe** 74 companies · $1.6B](https://millionrounds.com/top-lists/oncology-startups-europe)

## More lists worldwide

[See all](https://millionrounds.com/top-lists?r=Global)

[*GV* *V* *RP* **Health startups worldwide** 12,811 companies · $81B](https://millionrounds.com/top-lists/health-startups)[*O* *A* *X* **AI startups worldwide** 10,238 companies · $830B](https://millionrounds.com/top-lists/ai-startups)[*GV* *V* *RP* **Biotech startups worldwide** 7,127 companies · $70B](https://millionrounds.com/top-lists/biotech-startups)[*D* *B* *FT* **Big data startups worldwide** 3,812 companies · $220B](https://millionrounds.com/top-lists/big-data-startups)[*AF* *R* *S* **Fintech startups worldwide** 3,200 companies · $94B](https://millionrounds.com/top-lists/fintech-startups)[*O* *A* *B* **AI startups that raised in 2026** 2,922 companies · $540B in 2026](https://millionrounds.com/top-lists/ai-startups-raised-2026)[*FT* *CE* *P* **Energy providers startups worldwide** 2,808 companies · $152B](https://millionrounds.com/top-lists/energy-providers-startups)[*A* *P* *O* **Marketing tech startups worldwide** 2,728 companies · $28B](https://millionrounds.com/top-lists/marketing-tech-startups)